Get started
Work

Characterization of PCSK9 in the Blood and Skin of Psoriasis

Year: 2020
Type: article
Study design: Observational Study
DOI: 10.1016/j.jid.2020.05.115
Authors: Michael S. Garshick, Yvonne Baumer, Amit K. Dey, Ryan Grattan, Qimin Ng, Heather L. Teague, Zu-Xi Yu, Marcus Y. Chen, Michael Tawil, Tessa J. Barrett, James Underberg, Edward A. Fisher, James Krueger, Tiffany M. Powell-Wiley, Martin P. Playford, Jeffrey S. Berger, Nehal N. Mehta
Institutions: NYU Langone Health, New York University, National Institutes of Health, National Heart, Lung, and Blood Institute, Rockefeller University, National Heart, Lung, and Blood Institute Division of Intramural Research
Language: English
Subfield: Immunology
Open Access status: bronze
Funders: American Heart Association, American Society of Hematology, Dermatology Foundation, Amgen, National Psoriasis Foundation, Eli Lilly and Company, Pfizer, Novartis, National Institutes of Health, National Heart, Lung, and Blood Institute, National Center for Advancing Translational Sciences
Awards: G1189334091, G1406123821, G1859754121, G201439963, G2094403851, G2521280531, The Evaluation of Endothelial and Platelet Dysfunction in Those with Psoriasis, G5023810743, G5393666985, G6040946332, G6817824427, Platelet Activity and Vascular Health in Systemic Lupus Erythematosus, G9000028856, G9000084758, G9000100170, G9000137110, G9000248236, G9000279734, G9000287387, NRSA Training Core, G903119666
OpenAlex ID: W3037534331
FWCI: 1.517
Cites: 30
Cited by: 38
Related to: 10